Orthofix Medical Inc. (NASDAQ:OFIX) CFO Julie Andrews Sells 4,655 Shares

Orthofix Medical Inc. (NASDAQ:OFIX) CFO Julie Andrews sold 4,655 shares of the stock in a transaction on Thursday, January 16th. The stock was sold at an average price of $17.89, for a total value of $83,277.95. Following the completion of the sale, the chief financial officer now directly owns 28,312 shares in the company, valued at $506,501.68. This represents a 14.12 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Orthofix Medical Price Performance

NASDAQ:OFIX traded up $0.23 during mid-day trading on Tuesday, reaching $18.36. 128,087 shares of the stock were exchanged, compared to its average volume of 232,982. Orthofix Medical Inc. has a 1-year low of $12.08 and a 1-year high of $20.73. The company has a current ratio of 2.39, a quick ratio of 1.11 and a debt-to-equity ratio of 0.25. The firm has a market capitalization of $701.54 million, a PE ratio of -5.87 and a beta of 1.10. The business has a fifty day moving average price of $18.09 and a 200 day moving average price of $16.88.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. Stifel Nicolaus upgraded shares of Orthofix Medical from a “hold” rating to a “buy” rating and raised their price target for the company from $18.00 to $24.00 in a research note on Friday, November 8th. Roth Mkm restated a “buy” rating and set a $22.00 price target (up from $20.00) on shares of Orthofix Medical in a research report on Friday, November 8th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $23.00.

Hedge Funds Weigh In On Orthofix Medical

Several hedge funds have recently made changes to their positions in OFIX. Paradigm Capital Management Inc. NY raised its position in shares of Orthofix Medical by 31.3% during the second quarter. Paradigm Capital Management Inc. NY now owns 2,556,100 shares of the medical device company’s stock worth $33,894,000 after purchasing an additional 609,137 shares during the period. Engine Capital Management LP lifted its stake in Orthofix Medical by 11.0% during the second quarter. Engine Capital Management LP now owns 3,368,665 shares of the medical device company’s stock valued at $44,668,000 after buying an additional 333,364 shares in the last quarter. Marshall Wace LLP acquired a new position in shares of Orthofix Medical in the second quarter worth about $2,193,000. HighVista Strategies LLC purchased a new position in shares of Orthofix Medical in the third quarter worth approximately $1,689,000. Finally, JPMorgan Chase & Co. raised its holdings in shares of Orthofix Medical by 480.7% during the third quarter. JPMorgan Chase & Co. now owns 84,379 shares of the medical device company’s stock valued at $1,318,000 after acquiring an additional 69,848 shares during the period. Institutional investors and hedge funds own 89.76% of the company’s stock.

Orthofix Medical Company Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.